BioSyent Inc. (BIOYF)
OTCMKTS
· Delayed Price · Currency is USD
8.21
0.00 (0.00%)
Oct 28, 2024, 4:00 PM EDT
BioSyent Revenue
BioSyent had revenue of 8.94M CAD in the quarter ending June 30, 2024, with 12.33% growth. This brings the company's revenue in the last twelve months to 33.82M, up 17.86% year-over-year. In the year 2023, BioSyent had annual revenue of 31.59M with 13.12% growth.
Revenue (ttm)
33.82M CAD
Revenue Growth
+17.86%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
95.31M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 31.59M | 3.67M | 13.12% |
Dec 31, 2022 | 27.93M | -693.03K | -2.42% |
Dec 31, 2021 | 28.62M | 6.29M | 28.15% |
Dec 31, 2020 | 22.33M | 907.84K | 4.24% |
Dec 31, 2019 | 21.42M | -102.70K | -0.48% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 920.97M |
Vireo Growth Inc. | 98.04M |
Medexus Pharmaceuticals Inc. | 108.78M |
BioSyent News
- 2 months ago - BioSyent Releases Financial Results for Q2 and H1 2024 - GlobeNewsWire
- 2 months ago - BioSyent Declares Third Quarter 2024 Dividend - GlobeNewsWire
- 3 months ago - FAX Capital Files Early Warning Report Regarding Disposition of Common Shares of BioSyent Inc. - GlobeNewsWire
- 4 months ago - BioSyent In-Licenses Endocrinology Product for Canada - GlobeNewsWire
- 5 months ago - BioSyent Releases Financial Results for Q1 2024 - GlobeNewsWire
- 5 months ago - BioSyent Declares Second Quarter 2024 Dividend - GlobeNewsWire
- 6 months ago - BioSyent Schedules Q1 2024 Earnings Release for May 16, 2024 - GlobeNewsWire
- 6 months ago - BioSyent to Attend Planet MicroCap Showcase - GlobeNewsWire